This news is just one of the many signs pointing to the approval GW Pharma’s cannabinoid drug. In recent months, the company has also seen its new drug application approved by the FDA, received a cash injection of $276M (€235M), and been backed by Evaluate to join Genmab in the ‘blockbuster … Read More
The post Yet More Good News for GW Pharma’s Cannabinoid Drug Against Epilepsy appeared first on Dagga Magazine.